A potential role for olanzapine in the treatment of hyperemesis gravidarum

J Matern Fetal Neonatal Med. 2022 Dec;35(25):9532-9535. doi: 10.1080/14767058.2022.2046730. Epub 2022 Mar 3.

Abstract

Hyperemesis gravidarum is a rare but potentially serious complication of pregnancy. Some women with severe symptoms and possibly psychiatric comorbidities remain symptomatic despite the use of currently available treatments. Due to its favorable safety profile, antiemetic efficacy in other conditions, and 5-HT3 antagonism, olanzapine may be a potentially useful addition to the armamentarium for management of hyperemesis gravidarum resistant to standard- of-care treatment.

Keywords: Pregnancy; hyperemesis gravidarum; nausea; olanzapine; safety; treatment; vomiting.

MeSH terms

  • Antiemetics* / therapeutic use
  • Female
  • Humans
  • Hyperemesis Gravidarum* / drug therapy
  • Hyperemesis Gravidarum* / etiology
  • Olanzapine / therapeutic use
  • Pregnancy

Substances

  • Olanzapine
  • Antiemetics